Cystic Fibrosis (CFTR) PCR Detection Kit

Amplification-based NGS kit for complete CFTR gene analysis to identify mutations responsible for cystic fibrosis. Enables comprehensive detection of genetic variants associated with this genetic disorder.

PCR-CE FMR1 kit is a molecular diagnostic test for detecting FMR1 gene mutations associated with Fragile X Syndrome. The kit enables rapid and accurate identification of carrier status and disease presence, supporting genetic screening and diagnosis in maternal and pediatric healthcare settings.

PCR-based molecular diagnostic kit for genetic disease detection and identification. Utilizes polymerase chain reaction technology for accurate nucleic acid analysis.

Specialized PCR diagnostic kit for detection of rare genetic diseases. Targets uncommon genetic mutations and chromosomal abnormalities.

PCR-based molecular diagnostic testing kit designed for nucleic acid amplification and detection. Suitable for clinical and laboratory applications requiring high sensitivity and specificity in pathogen or genetic material identification.

Diagnostic kit using PCR methodology for identifying genetic mutations and polymorphisms. Supports clinical diagnosis of genetic disorders and carrier screening.

A molecular diagnostics reagent kit for human CYP2C19 gene typing using PCR with fluorescent probes. The kit supports pharmacogenetic testing for personalized medicine applications.

A molecular diagnostic kit designed for the detection of C-KIT mutations. Used in oncology and haematology applications for identifying specific genetic mutations associated with various malignancies.

Molecular diagnostic kit for detecting Chlamydia trachomatis nucleic acids using PCR fluorescent probe methodology. Provides rapid, specific, and sensitive detection for early diagnosis of asymptomatic or mild infections.

A molecular diagnostics reagent kit for human MTHFR gene typing using PCR with fluorescent probes. The kit enables genetic analysis for clinical and personalized medicine applications.

Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.

Molecular diagnostic kit for identification of specific genetic mutations associated with disease or resistance. Enables targeted diagnostic and therapeutic decision-making.